Affinivax's Series A Round

Affinivax raised a round of funding on October 30, 2014. Investors include Bill & Melinda Gates Foundation.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious disease…

Articles about Affinivax's Series A Round: